Stress-Responsive Sestrins Link p53 with Redox Regulation and Mammalian Target of Rapamycin Signaling

被引:141
|
作者
Budanov, Andrei V. [1 ]
机构
[1] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA
关键词
ACTIVATED PROTEIN-KINASE; DNA-DAMAGE RESPONSE; LIFE-SPAN; OXIDATIVE STRESS; ANTIOXIDANT FUNCTION; TUMOR-SUPPRESSOR; MITOCHONDRIAL DYSFUNCTION; TRANSCRIPTION FACTORS; TUBEROUS SCLEROSIS; UP-REGULATION;
D O I
10.1089/ars.2010.3530
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor p53 protects organisms from most types of cancer through multiple mechanisms. The p53 gene encodes a stress-activated transcriptional factor that transcriptionally regulates a large set of genes with versatile functions. These p53-activated genes mitigate consequences of stress regulating cell viability, growth, proliferation, repair, and metabolism. Recently, we described a novel antioxidant function of p53, which is important for its tumor suppressor activity. Among the many antioxidant genes activated by p53, Sestrins (Sesns) are critical for suppression of reactive oxygen species (ROS) and protection from oxidative stress, transformation, and genomic instability. Sestrins can regulate ROS through their direct effect on antioxidant peroxiredoxin proteins and through the AMP-activated protein kinase-target of rapamycin signaling pathway. The AMP-activated protein kinase-target of rapamycin axis is critical for regulation of metabolism and autophagy, two processes associated with ROS production, and deregulation of this pathway increases vulnerability of the organism to stress, aging, and age-related diseases, including cancer. Recently, we have shown that inactivation of Sestrin in fly causes accumulation of age-associated damage. Hence, Sestrins can link p53 with aging and age-related diseases. Antioxid. Redox Signal. 15, 1679-1690.
引用
收藏
页码:1679 / 1690
页数:12
相关论文
共 50 条
  • [41] Regulation of p53 stability and activity in response to genotoxic stress
    Colman, MS
    Afshari, CA
    Barrett, JC
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2000, 462 (2-3) : 179 - 188
  • [42] Regulation of p53 target gene expression by peptidylarginine deiminase 4
    Li, Pingxin
    Yao, Hongjie
    Zhang, Zhiqiang
    Li, Ming
    Luo, Yuan
    Thompson, Paul R.
    Gilmour, David S.
    Wang, Yanming
    MOLECULAR AND CELLULAR BIOLOGY, 2008, 28 (15) : 4745 - 4758
  • [43] BRCA1 regulation of p53 stability and target expression
    Scata, Kimberly A.
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2006, 66 (08)
  • [44] miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin
    Han, Jia
    Li, Jie
    Tang, Kaijie
    Zhang, Huahua
    Guo, Bo
    Hou, Ni
    Huang, Chen
    EXPERIMENTAL CELL RESEARCH, 2017, 360 (02) : 328 - 336
  • [45] Autophagy suppresses TRP53/p53 and oxidative stress to enable mammalian survival
    Yang, Yang
    White, Eileen
    AUTOPHAGY, 2020, 16 (07) : 1355 - 1357
  • [46] Selenomethionine regulation of p53 by a Ref1-mediated redox mechanism
    Seo, YR
    Kelley, MR
    Smith, ML
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1229S - 1229S
  • [47] Rapamycin and p53 act on different pathways to induce G1 arrest in mammalian cells
    Metcalfe, SM
    Canman, CE
    Milner, J
    Morris, RE
    Goldman, S
    Kastan, MB
    ONCOGENE, 1997, 15 (14) : 1635 - 1642
  • [48] Cordycepin Suppresses Angiogenesis through Regulation of FAK and p53 Signaling
    Lin, Yi-Ting
    Liang, Shu-Man
    Lu, Yi-Jhu
    Kuo, Cheng-Chin
    Liou, Jun-Yang
    CANCER SCIENCE, 2018, 109 : 1037 - 1037
  • [49] Selenomethionine regulation of p53 by a ref1-dependent redox mechanism
    Seo, YR
    Kelley, MR
    Smith, ML
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (22) : 14548 - 14553
  • [50] Rapamycin and p53 act on different pathways to induce G1 arrest in mammalian cells
    S M Metcalfe
    C E Canman
    J Milner
    R E Morris
    S Goldman
    M B Kastan
    Oncogene, 1997, 15 : 1635 - 1642